Literature DB >> 32929254

Optimizations to keep gonorrhoea treatable and reduce antimicrobial resistance selection.

Magnus Unemo1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32929254     DOI： 10.1038/s41585-020-00378-5

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  6 in total

Review 1.  Wild-Type Gyrase A Genotype of Neisseria gonorrhoeae Predicts In Vitro Susceptibility to Ciprofloxacin: A Systematic Review of the Literature and Meta-Analysis.

Authors:  Lao-Tzu Allan-Blitz; Xiaoyan Wang; Jeffrey D Klausner
Journal:  Sex Transm Dis       Date:  2017-05       Impact factor: 2.830

Review 2.  Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae.

Authors:  Valentina Donà; Nicola Low; Daniel Golparian; Magnus Unemo
Journal:  Expert Rev Mol Diagn       Date:  2017-08-03       Impact factor: 5.225

3.  S-100 protein in human chondrocytes.

Authors:  K Stefansson; R L Wollmann; B W Moore; B G Arnason
Journal:  Nature       Date:  1982-01-07       Impact factor: 49.962

Review 4.  Gonorrhoea.

Authors:  Magnus Unemo; H Steven Seifert; Edward W Hook; Sarah Hawkes; Francis Ndowa; Jo-Anne R Dillon
Journal:  Nat Rev Dis Primers       Date:  2019-11-21       Impact factor: 52.329

5.  Developing target product profiles for Neisseria gonorrhoeae diagnostics in the context of antimicrobial resistance: An expert consensus.

Authors:  Cecilia Ferreyra; Jennifer Osborn; Francis Moussy; Emilie Alirol; Monica Lahra; David Whiley; William Shafer; Magnus Unemo; Jeffrey Klausner; Cassandra Kelly Cirino; Teodora Wi
Journal:  PLoS One       Date:  2020-09-01       Impact factor: 3.240
  6 in total
  1 in total

1.  Assessment of Serum Bactericidal and Opsonophagocytic Activity of Antibodies to Gonococcal Vaccine Targets.

Authors:  Evgeny A Semchenko; Freda E-C Jen; Michael P Jennings; Kate L Seib
Journal:  Methods Mol Biol       Date:  2022
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.